File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Simplified solid-phase extraction for measurement of F2-isoprostanes in human plasma and urine

TitleSimplified solid-phase extraction for measurement of F2-isoprostanes in human plasma and urine
Authors
Issue Date2004
PublisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/plefa
Citation
The 1st European Workshop on Isoprostane Research: Chemistry, Biochemistry, Physiology and Pharmacology, Montpellier, France, 28-30 June 2004 . In Prostaglandins, Leukotrienes & Essential Fatty Acids, 2004, v. 71 n. 1, p. 54 How to Cite?
AbstractSeveral methods for measuring F2-isoprostanes have been established in recent years, namely GC-MS [1], LC-MS [2], EIA [3], RIA [4]. Although quantitative methods by chromatography have been developed, further improvements are still required to reduce the number of steps for sample preparation. Most sample preparation for chromatographic analysis involves solid-phase extraction (SPE) followed by a further purification by TLC or HPLC. In this study, the authors were able to establish a rapid one-step method by preparing the samples by anion exchange SPE, which is highly selective for acidic compounds. Hydrolyzed plasma and urine samples of healthy individuals were acidified before SPE. The eluted samples were first derivatized with pentafluorobenzyl bromide followed by a second derivatization with bis-(trimethylsiyl)trifluoroacetamide. F2-isoprostanes were analyzed by GC–MSD–NCI. Our data showed that anion exchange SPE prior to GC–MSD–NCI analysis for determining F2-isoprostane in biological fluids is robust, time saving and less laborious in comparison to other methods reported.
Persistent Identifierhttp://hdl.handle.net/10722/181631
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 0.805
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLee, JCY-
dc.contributor.authorJenner, AM-
dc.contributor.authorHalliwell, B-
dc.date.accessioned2013-03-19T01:13:58Z-
dc.date.available2013-03-19T01:13:58Z-
dc.date.issued2004-
dc.identifier.citationThe 1st European Workshop on Isoprostane Research: Chemistry, Biochemistry, Physiology and Pharmacology, Montpellier, France, 28-30 June 2004 . In Prostaglandins, Leukotrienes & Essential Fatty Acids, 2004, v. 71 n. 1, p. 54-
dc.identifier.issn0952-3278-
dc.identifier.urihttp://hdl.handle.net/10722/181631-
dc.description.abstractSeveral methods for measuring F2-isoprostanes have been established in recent years, namely GC-MS [1], LC-MS [2], EIA [3], RIA [4]. Although quantitative methods by chromatography have been developed, further improvements are still required to reduce the number of steps for sample preparation. Most sample preparation for chromatographic analysis involves solid-phase extraction (SPE) followed by a further purification by TLC or HPLC. In this study, the authors were able to establish a rapid one-step method by preparing the samples by anion exchange SPE, which is highly selective for acidic compounds. Hydrolyzed plasma and urine samples of healthy individuals were acidified before SPE. The eluted samples were first derivatized with pentafluorobenzyl bromide followed by a second derivatization with bis-(trimethylsiyl)trifluoroacetamide. F2-isoprostanes were analyzed by GC–MSD–NCI. Our data showed that anion exchange SPE prior to GC–MSD–NCI analysis for determining F2-isoprostane in biological fluids is robust, time saving and less laborious in comparison to other methods reported.-
dc.languageeng-
dc.publisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/plefa-
dc.relation.ispartofProstaglandins, Leukotrienes & Essential Fatty Acids-
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in Prostaglandins, Leukotrienes & Essential Fatty Acids. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Prostaglandins, Leukotrienes & Essential Fatty Acids, [VOL 71, ISSUE 1, 2004] DOI 10.1016/j.plefa.2004.03.013-
dc.titleSimplified solid-phase extraction for measurement of F2-isoprostanes in human plasma and urineen_US
dc.typeConference_Paperen_US
dc.identifier.emailLee, JCY: jettylee@hku.hk-
dc.description.natureabstract-
dc.identifier.doi10.1016/j.plefa.2004.03.013-
dc.identifier.volume71-
dc.identifier.issue1-
dc.identifier.spage54-
dc.identifier.epage54-
dc.identifier.isiWOS:000222074600006-
dc.publisher.placeUnited Kingdom-
dc.description.otherThe 1st European Workshop on Isoprostane Research: Chemistry, Biochemistry, Physiology and Pharmacology, Montpellier, France, 28-30 June 2004 . In Prostaglandins, Leukotrienes & Essential Fatty Acids, 2004, v. 71 n. 1, p. 54-
dc.identifier.issnl0952-3278-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats